Lyken.AI和Clairvoyant Holdings同意探讨AI驱动的健康平台整合问题,在等待批准之前,可能价值150万加元。 Lyken.AI and Clairvoyant Holdings agree to explore AI-driven health platform integration, potentially worth C$1.5M, pending approvals.

Lyken.AI是Alset AI的单位,它与卫生技术公司Clairvoyant Holdings Inc.签署了一份不具约束力的协议,探索如何利用Lyken的AI和云服务来增强CHI的临床和健康平台。 Lyken.AI, a unit of Alset AI, has signed a non-binding agreement with health tech firm Clairvoyant Holdings Inc. to explore using Lyken’s AI and cloud services to enhance CHI’s clinical and wellness platforms. 拟议的合作可在24个月内带来150万科多巴元的付款,其中大部分将用于技术服务,一部分用于Silver Birch增长,用于商业支持。 The proposed collaboration could bring about C$1.5 million in payments over 24 months, with most going to Lyken for tech services and a portion to Silver Birch Growth for commercial support. 这项交易需要董事会和监管机构的批准,并可能涉及因所有权关系而产生的关联方规则,但没有得到保证,预计将在2026年6月1日之后完成。 The deal, which requires board and regulatory approval and may involve related-party rules due to ownership ties, is not guaranteed and is expected to be finalized after June 1, 2026.